Correlation between CMV genotypes, multiple infections with herpesviruses (HHV-6, 7) and development of CMV disease in kidney recipients in Kuwait

FEMS Immunology and Medical Microbiology

Volumn 35, Issue 2, 2003, Pages 125-130

  Pacsa, A S ^a   Essa, S ^a   Voevodin, A ^a   El Shazly, A ^a   Kazak, H ^a   Nampoory, M R N ^b   Johny, K V ^b   Said, T ^b   Al Nakib, W ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

Author keywords

CMV genotypes; HHV 6; HHV 7; Kidney transplant recipients

Indexed keywords

GLYCOPROTEIN B; STRUCTURAL PROTEIN; VIRUS ANTIGEN;

ADULT; ANALYTIC METHOD; ARTICLE; CADAVER; CELL COUNT; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DNA DETERMINATION; DONOR; FEMALE; GENE AMPLIFICATION; GENETIC CODE; GENOTYPE; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN TISSUE; KIDNEY; KIDNEY GRAFT; KUWAIT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SUPERINFECTION;

EID: 0037456635     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00006-3     Document Type: Article

References (30)

1. Jeffries D.J. The spectrum of cytomegalovirus infection and management. J. Antimicrob. Chemother. 23S:1989;1-10.
2. Gehrz R.C., Rutzik S.R. CMV-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes. Clin. Exp. Immunol. 61:1985;80-89.
3. Rook A.H., Quinnan G.V., Frederick W.J., Manischewitz J.F., Kirmani N., Dantzler T., Lee B.B., Currier C.B. Jr. Importance of cytotoxic lymphocytes during CMV infection of renal transplant recipients. Am. J. Med. 76:1984;385-392.
4. Betts R.F., Freeman R.B., Douglas R.G., Talley T.E., Rundell B. Transmission of CMV infection with renal allograft. Kidney Int. 6:1975;387-394.
5. Chou S., Norman D.J. The influence of donor factors other than serologic status on transmission of CMV to transplant recipients. Transplantation. 46:1988;84-93.
6. Grundy J.E., Super M., Sweny P. Symptomatic CMV infection in seropositive kidney recipients, reinfection with donor strain rather than reactivation of recipient virus. Lancet. 2:1988;132-135.
7. Van Son W.J., The T.H. Cytomegalovirus infection after organ transplantation: an update with special emphasis on renal transplantation. Transpl. Int. 2:1989;147-164.
8. Pacsa A.S., El-Shazly A., Gupta R.K., Nampoory N.M.R., Said T., Gadalla N., Essa S. Diagnosis of cytomegalovirus infection by the detection of early antigen (pp65) in leukocytes of kidney transplant patients. Med. Princ. Pract. 8:1999;85-90.
9. Fries B.C., Chou S.W., Boeckh M., Torok-Storb B. Frequency distribution of CMV envelope glycoprotein genotypes in bone marrow transplant recipients. J. Infect. Dis. 169:1994;769-774.
10. Shepp D., Match M., Ashraf A., Lipson S.M., Millan C., Pergolizzi R. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J. Infect. Dis. 174:1996;184-187.
11. Cone R.W., Hackman R.C., Huang M.L., Bowden R.A., Meyers J.D., Metcalf M., Zeh J., Ashley R., Corey L. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone-marrow transplantation. New Engl. J. Med. 329:1993;156-161.
12. Cone R.W., Huang M.L., Corey L., Corey L., Zeh J., Ashley R., Bowden R. Human herpesvirus 6 infections after bone-marrow transplantation: clinical and virologic manifestations. J. Infect. Dis. 179:1999;311-318.
13. Dockrell D.H., Smith T.F., Paya C.V. Human herpesvirus 6. Mayo Clin. Proc. 74:1999;163-170.
14. Tong C.Y., Bakran A., Williams H., Cheung C.Y., Peiris J.S. Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients. Transplantation. 70:2000;213-216.
15. Vogelberg C., Meyer-Konig U., Hufert F.T., Kirste G., von Laer D. Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients. J. Med. Virol. 50:1996;31-34.
16. Chou S.W., Dennison K.M. Analysis of interstrain variation in CMV glycoprotein B sequences encoding neutralisation epitopes. J. Infect. Dis. 163:1991;29-1234.
17. Meyer-Konig U., Vogelberg C., Bongarts A., Kampa D., Delbruck R., Wolff-Vorbeck G., Kirste G., Haberland M., Hufert F.T., von Laer D. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J. Med. Virol. 55:1998;75-81.
18. The T.H., van der Ploeg M., van den Berg A.P., Vlieger A.M., van der Giessen M., van Son W.J. Direct detection of cytomegalovirus in peripheral blood leukocytes: a review of the antigenemia assay and polymerase chain reaction. Transplantation. 54:1992;193-198.
19. Brennan D.C. Cytomegalovirus in renal transplantation. J. Am. Soc. Nephrol. 12:2001;848-855.
20. Landry M.L., Freguson D. 2-Hour cytomegalovirus pp65 antigenemia assay for rapid quantitation of cytomegalovirus in blood samples. J. Clin. Microbiol. 38:2000;427-428.
21. Boivin G., Belanger R., Delage R., Beliveau C., Demers C., Goyette N., Roy J. Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation. J. Clin. Microbiol. 38:2000;4356-4360.
22. Tugizov S., Navarro D., Paz P., Wang Y., Qadri I., Pereira L. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. Virology. 201:1994;263-276.
23. Chou S., Lurain N.S., Weinberg A., Cai G.Y., Sharma P.L., Crumpacker C.S. Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. Antimicrob. Agents Chemother. 43:1999;1500-1502.
24. Rasmussen L., Hong C., Zipeto D., Morris S., Sherman D., Chou S., Miner R., Drew W.L., Wolitz R., Dowling A., Warford A., Merigan T.C. Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J. Infect. Dis. 175:1997;179-184.
25. Aquino V.H., Figueiredo L.T. High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype. J. Med. Virol. 61:2000;138-142.
26. Osman H.K., Peiris J.S., Taylor C.E., Warwicker P., Jarrett R.F., Madeley C.R. 'Cytomegalovirus disease' in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression? J. Med. Virol. 48:1996;295-301.
27. DesJardin J.A., Gibbons L., Cho E., Supran S.E., Falagas M.E., Werner B.G., Snydman D.R. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J. Infect. Dis. 178:1998;1783-1786.
28. Ratnamohan V.M., Chapman J., Howse H., Bovington K., Robertson P., Byth K., Allen R., Cunningham A.L. Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation. Transplantation. 66:1998;877-882.
29. Kidd I.M., Clark D.A., Sabin C.A., Andrew D., Hassan-Walker A.F., Sweny P., Griffith P.D., Emery V.C. Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation. 69:2000;2400-2404.
30. Mendez J.C., Dockrell D.H., Espy M.J., Smith T.F., Wilson J.A., Harmsen W.S., Ilstrup D., Paya C.V. Human beta-herpesvirus interactions in solid organ transplant recipients. J. Inf. Dis. 183:2001;179-184.